iShares MSCI India ETF vs Revolution Medicines Inc. Common Stock — how do they compare? iShares MSCI India ETF trades at $46.03 (market cap $5.73B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 7× iShares MSCI India ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI India ETF for 58 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| INDA | RVMD | |
|---|---|---|
Market Cap | $5.73B | $40.32B |
Volume | 6,797,522 | 4,855,734 |
Sector | Broad Market / Factor | Health |
52-Week High | $55.29 | $221.15 |
52-Week Low | $45.42 | $47.50 |
Typical Hold Time | 58 Days | 0 Days |
Enterprise Value | — | $37.02B |
Signals from Pluang's Aura AI — not financial advice
INDA trades at $46.03, down 0.2% on the day, with a bearish technical signal driven by moving averages and oscillators. Key financial ratios are unavailable in the provided data, limiting fundamental assessment. Recent news highlights India's economic growth amid sector-specific challenges, including energy security concerns and pharmaceutical export hurdles, which may influence the ETF's underlying holdings.
The outlook remains cautious due to technical weakness and macroeconomic headwinds in India. Opportunities exist if oversold conditions reverse, but risks include regulatory tensions and sector volatility. Investors should await updated financials for a clearer fundamental picture.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →